← Leaderboards
Tyrone Porter
Boston University (Charles River Campus)
$3,184,103
Attributed
$3,519,773
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $547.1K · FY2010–20$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,519,773 · 6
By mechanism
R01$1,751,110 · 1
R21$1,412,162 · 3
T32$197,466 · 1
R03$159,035 · 1
Top collaborators
- Suryaram Gummuluru2 shared
- Mark W Grinstaff1 shared
Most similar at Boston University (Charles River Campus)
Same institution · by research overlap
- Vinod K Sarin$436,409
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesIn VivoTumorMediatingNanoemulsionIn VitroPhysiologic PulseSolid NeoplasmAcousticsUltrasonographyFocused Ultrasound TherapyMalignant NeoplasmsTechnologyResponseBlood CirculationPressureCancer TherapyProtocols DocumentationAdverse EffectsMonitorLocationImmunotherapyHourCells
Grant awards (14)
Translational Research in Biomaterials$197,466
T32 · FY2020 · EB
Focal ultrasound-mediated nonthermal ablation of brain tumors$196,710
R21 · FY2020 · EB · contact PI
Focal ultrasound-mediated nonthermal ablation of brain tumors$25,387
R21 · FY2020 · EB · contact PI
Focal ultrasound-mediated nonthermal ablation of brain tumors$269,662
R21 · FY2019 · EB · contact PI
Engineering a 3D human neurovascular unit for investigating and countering neuroinflammatory mechanisms of HIV$208,500
R21 · FY2018 · NS · contact PI
Engineering a 3D human neurovascular unit for investigating and countering neuroinflammatory mechanisms of HIV$265,375
R21 · FY2017 · NS · contact PI
Enhancing ultra-sound-mediated tumor ablation with phase-shift nanoemulation$455,924
R01 · FY2016 · EB · contact PI
Enhancing ultra-sound-mediated tumor ablation with phase-shift nanoemulation$421,032
R01 · FY2015 · EB · contact PI
Enhancing ultra-sound-mediated tumor ablation with phase-shift nanoemulation$404,211
R01 · FY2014 · EB · contact PI
Enhancing ultra-sound-mediated tumor ablation with phase-shift nanoemulation$469,943
R01 · FY2013 · EB · contact PI
Neutral pressure-sensitive nanoemulsion for localized siRNA delivery$77,185
R03 · FY2013 · EB · contact PI
Neutral pressure-sensitive nanoemulsion for localized siRNA delivery$81,850
R03 · FY2012 · EB · contact PI
MRI-guided HIFU-mediated heating and lesion formation enhanced with phase-shift n$191,179
R21 · FY2011 · EB · contact PI
MRI-guided HIFU-mediated heating and lesion formation enhanced with phase-shift n$255,349
R21 · FY2010 · EB · contact PI